Johnson & Johnson’s stock rose 2.4% in premarket trading, enough to pace the Dow Jones Industrial Average’s early gainers.

June inflation data released Tuesday represented an increase from May levels, despite the headline numbers matching ...

Schindler backed its full-year guidance after posting a rise in earnings in the first half of the year. The Swiss elevator maker said Friday that net profit rose to 531 million Swiss francs ($660 ...

Sen. Elizabeth Warren sent letters Thursday to agencies including S&P Global Ratings, Moody's Ratings and Fitch Ratings, asking for information about how they score the riskiness of private-credit ...

U.S. Bancorp notched a rise in earnings for the latest quarter as it benefited from a lower loan-loss provision and growth in fee income. The healthcare-products maker trimmed and narrowed its ...

Stocks rose Thursday as investors responded to a flurry of quarterly earnings reports from major companies and better-than-expected retail sales data.

Johnson & Johnson is leading the S&P 500 and the Dow Jones Industrial Average after the drugmaker slashed its estimate for the impact of tariffs in 2025 and raised its outlook. The company’s stock is ...

With Wall Street's surge to record highs, the U.S. stock market looks nearly as expensive as ever, and investors are debating ...

Johnson & Johnson shares fell slightly Thursday after soaring yesterday amid investor optimism about the company's ...

U.S. stock futures dipped as investors absorbed mixed inflation data and braced for more economic reports. Several major U.S.

Ten stocks finished the trading session in a lackluster note amid a series of negative news, including bearish ratings and ...